Natco Pharma share price rose after the company on Wednesday announced that its wholly owned Canadian subsidiary, NATCO Pharma Inc, has made an investment of $8 million in eGenesis
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
